Shawn D. Bridy
Corporate Officer/Principal bij INOVIO PHARMACEUTICALS, INC.
Profiel
Shawn D.
Bridy is currently the Vice President-Business Development at Inovio Pharmaceuticals, Inc. He previously worked as the Head-Business Development & Licensing at Immunome, Inc. from 2014 to 2017.
He also held the position of Vice President-Business Development & Strategy at BTG Ltd.
Mr. Bridy completed his undergraduate degree at Miami University and his graduate and MBA degrees at Villanova University.
Actieve functies van Shawn D. Bridy
| Bedrijven | Functie | Begin |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 24-05-2018 |
Eerdere bekende functies van Shawn D. Bridy
| Bedrijven | Functie | Einde |
|---|---|---|
| IMMUNOME, INC. | Corporate Officer/Principal | 01-01-2017 |
| BTG | Corporate Officer/Principal | - |
Opleiding van Shawn D. Bridy
| Miami University | Undergraduate Degree |
| Villanova University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
